🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/09/2018 | 167,40 | 170,92 | 165,66 | 168,90 | +0,89% | 3,14% | 504.304 |
| 24/09/2018 | 162,56 | 167,87 | 160,95 | 167,40 | +3,27% | 4,25% | 740.907 |
| 21/09/2018 | 160,89 | 162,86 | 159,57 | 162,10 | +0,80% | 2,04% | 1.099.498 |
| 20/09/2018 | 165,62 | 166,56 | 160,62 | 160,81 | -2,42% | 3,59% | 570.347 |
| 19/09/2018 | 166,47 | 167,64 | 163,91 | 164,80 | -0,58% | 2,24% | 735.456 |
| 18/09/2018 | 167,19 | 170,46 | 164,16 | 165,76 | +4,75% | 3,77% | 1.009.890 |
| 17/09/2018 | 158,86 | 159,42 | 154,82 | 158,25 | -0,44% | 2,89% | 604.812 |
| 14/09/2018 | 159,62 | 160,94 | 156,64 | 158,95 | -0,41% | 2,69% | 520.013 |
| 13/09/2018 | 160,35 | 160,95 | 156,28 | 159,60 | -0,28% | 2,91% | 557.363 |
| 12/09/2018 | 161,34 | 161,98 | 154,96 | 160,06 | -0,78% | 4,35% | 685.763 |
| 11/09/2018 | 160,47 | 162,47 | 158,93 | 161,32 | +0,89% | 2,20% | 578.042 |
| 10/09/2018 | 159,78 | 161,09 | 157,84 | 159,90 | +0,70% | 2,03% | 472.564 |
| 07/09/2018 | 156,09 | 161,25 | 153,44 | 158,79 | +1,10% | 5,01% | 541.814 |
| 06/09/2018 | 159,24 | 160,95 | 156,47 | 157,07 | -1,03% | 2,81% | 580.767 |
| 05/09/2018 | 160,30 | 160,38 | 155,16 | 158,70 | -1,59% | 3,26% | 588.141 |
| 04/09/2018 | 162,46 | 162,46 | 157,21 | 161,25 | -0,46% | 3,24% | 612.827 |
| 31/08/2018 | 160,34 | 163,03 | 159,69 | 162,00 | +0,80% | 2,08% | 435.856 |
| 30/08/2018 | 159,51 | 162,13 | 159,10 | 160,71 | +0,37% | 1,90% | 434.894 |
| 29/08/2018 | 159,36 | 160,49 | 156,72 | 160,11 | +0,92% | 2,36% | 448.199 |
| 28/08/2018 | 161,26 | 161,78 | 156,19 | 158,65 | -1,03% | 3,47% | 494.045 |
| 27/08/2018 | 157,93 | 161,84 | 156,82 | 160,30 | +2,24% | 3,18% | 497.411 |
| 24/08/2018 | 156,49 | 158,07 | 155,91 | 156,78 | +0,54% | 1,38% | 399.307 |
| 23/08/2018 | 153,83 | 157,07 | 153,83 | 155,94 | +0,94% | 2,11% | 415.818 |
| 22/08/2018 | 152,21 | 156,85 | 150,50 | 154,49 | +1,41% | 4,17% | 524.822 |
| 21/08/2018 | 150,54 | 153,67 | 148,71 | 152,34 | +1,93% | 3,29% | 617.796 |
| 20/08/2018 | 154,84 | 155,60 | 147,47 | 149,45 | -3,39% | 5,25% | 708.847 |
| 17/08/2018 | 148,52 | 154,78 | 147,67 | 154,70 | +3,47% | 4,78% | 915.954 |
| 16/08/2018 | 155,45 | 156,43 | 148,45 | 149,51 | -3,12% | 5,13% | 788.035 |
| 15/08/2018 | 154,75 | 154,75 | 152,21 | 154,32 | -0,70% | 1,64% | 402.834 |
| 14/08/2018 | 154,66 | 159,31 | 153,47 | 155,40 | +0,61% | 3,78% | 735.456 |